222 related articles for article (PubMed ID: 26723908)
21. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
22. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
23. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
24. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
[TBL] [Abstract][Full Text] [Related]
25. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.
Boda-Heggemann J; Hofheinz RD; Weiss C; Mennemeyer P; Mai SK; Hermes P; Wertz H; Post S; Massner B; Hieber U; Hochhaus A; Wenz F; Lohr F
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1187-95. PubMed ID: 19409725
[TBL] [Abstract][Full Text] [Related]
26. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
27. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in postoperative radiotherapy in salivary gland carcinoma: A single institution experience from Turkey.
Kandaz M; Soydemir G; Bahat Z; Canyılmaz E; Yöney A
Indian J Cancer; 2016; 53(2):274-279. PubMed ID: 28071626
[TBL] [Abstract][Full Text] [Related]
29. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
Hoppe BS; Nelson CJ; Gomez DR; Stegman LD; Wu AJ; Wolden SL; Pfister DG; Zelefsky MJ; Shah JP; Kraus DH; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):763-9. PubMed ID: 18395361
[TBL] [Abstract][Full Text] [Related]
30. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
31. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of lymph node density in high-grade salivary gland cancers.
Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
[TBL] [Abstract][Full Text] [Related]
33. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
Hoppe BS; Stegman LD; Zelefsky MJ; Rosenzweig KE; Wolden SL; Patel SG; Shah JP; Kraus DH; Lee NY
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):691-702. PubMed ID: 17161557
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
35. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer.
Hanson M; McGill M; Mimica X; Eagan A; Hay A; Wu J; Cohen MA; Patel SG; Ganly I
JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):128-138. PubMed ID: 34854898
[TBL] [Abstract][Full Text] [Related]
38. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
[TBL] [Abstract][Full Text] [Related]
39. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
[TBL] [Abstract][Full Text] [Related]
40. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]